|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-10
|
|
pubmed:abstractText |
Photodynamic therapy (PDT) is increasingly used for the treatment of patients with Barrett's esophagus (BE) with dysplasia or early carcinoma. Post-PDT, some patients show residual BE either exposed to the luminal surface (nonburied) or buried underneath reepithelialized squamous mucosa (buried BE). Buried BE may be a serious clinical problem since it can go unnoticed during surveillance endoscopies. The neoplastic potential of buried BE is poorly understood. The aim of this study was to evaluate the biological characteristics of nonburied and buried BE in patients treated with PDT.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
38-47
|
|
pubmed:meshHeading |
pubmed-meshheading:18076737-Aged,
pubmed-meshheading:18076737-Aged, 80 and over,
pubmed-meshheading:18076737-Barrett Esophagus,
pubmed-meshheading:18076737-Biopsy,
pubmed-meshheading:18076737-Cell Proliferation,
pubmed-meshheading:18076737-Cyclin D1,
pubmed-meshheading:18076737-DNA,
pubmed-meshheading:18076737-Endoscopy, Gastrointestinal,
pubmed-meshheading:18076737-Female,
pubmed-meshheading:18076737-Follow-Up Studies,
pubmed-meshheading:18076737-Humans,
pubmed-meshheading:18076737-Immunohistochemistry,
pubmed-meshheading:18076737-Intestinal Mucosa,
pubmed-meshheading:18076737-Ki-67 Antigen,
pubmed-meshheading:18076737-Male,
pubmed-meshheading:18076737-Middle Aged,
pubmed-meshheading:18076737-Photochemotherapy,
pubmed-meshheading:18076737-Photosensitizing Agents,
pubmed-meshheading:18076737-Retrospective Studies,
pubmed-meshheading:18076737-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities.
|
|
pubmed:affiliation |
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|
